In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 2213-63-0, name is 2,3-Dichloroquinoxaline, introducing its new discovery. Application In Synthesis of 2,3-Dichloroquinoxaline
Heterocyclic Systems Containing Bridgehead Nitrogen Atom : Syntheses of s-Triazolo<3,4-b><1,3,4>thiadiazin-6(5H)-one, s-Triazolo<3',4':2,3><1,3,4>thiadiazino<5,6-b>quinoxalines and s-Triazolo<3,4-b><1,3,4>thiadiazines
7H-3-n-Pentyl-s-triazolo<3,4-b><1,3,4>thiadiazin-6(5H)-one (III), 5H-3-substituted-s-triazolo<3',4':2,3><1,3,4>thiadiazino<5,6-b>quinoxalines (IV) and 7H-3,6-disubstituted-s-triazolo<3,4-b><1,3,4>thiadiazines (V) have been synthesized by the reaction of the appropriate 4-amino-5-mercapto-3-substituted-s-triazoles (IIa-d) with chloroacetic acid, 2,3-dichloroquinoxaline and alpha-halogenoketones, respectively.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 2213-63-0, and how the biochemistry of the body works.Application In Synthesis of 2,3-Dichloroquinoxaline
Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1451 | ChemSpider